Cargando…
Would Fred Sanger Get Funded Today?
Fred Sanger developed technologies that won him two Nobel Prizes and revolutionized biological research. Yet, in spite of this record, the question has been raised as to whether, in the current scientific climate, he might be unsuccessful in obtaining a grant because of a productivity that would be...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063904/ https://www.ncbi.nlm.nih.gov/pubmed/24939989 http://dx.doi.org/10.1534/genetics.114.165134 |
_version_ | 1782321873094180864 |
---|---|
author | Fields, Stanley |
author_facet | Fields, Stanley |
author_sort | Fields, Stanley |
collection | PubMed |
description | Fred Sanger developed technologies that won him two Nobel Prizes and revolutionized biological research. Yet, in spite of this record, the question has been raised as to whether, in the current scientific climate, he might be unsuccessful in obtaining a grant because of a productivity that would be viewed as too limited. In imagining how a National Institutes of Health study section today might treat a proposal from Sanger to sequence DNA, we can ask whether there are lessons from his career that suggest changes to the grant review process. |
format | Online Article Text |
id | pubmed-4063904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Genetics Society of America |
record_format | MEDLINE/PubMed |
spelling | pubmed-40639042015-06-01 Would Fred Sanger Get Funded Today? Fields, Stanley Genetics Perspectives Fred Sanger developed technologies that won him two Nobel Prizes and revolutionized biological research. Yet, in spite of this record, the question has been raised as to whether, in the current scientific climate, he might be unsuccessful in obtaining a grant because of a productivity that would be viewed as too limited. In imagining how a National Institutes of Health study section today might treat a proposal from Sanger to sequence DNA, we can ask whether there are lessons from his career that suggest changes to the grant review process. Genetics Society of America 2014-06 2014 /pmc/articles/PMC4063904/ /pubmed/24939989 http://dx.doi.org/10.1534/genetics.114.165134 Text en Copyright © 2014 by the Genetics Society of America Available freely online through the author-supported open access option. |
spellingShingle | Perspectives Fields, Stanley Would Fred Sanger Get Funded Today? |
title | Would Fred Sanger Get Funded Today? |
title_full | Would Fred Sanger Get Funded Today? |
title_fullStr | Would Fred Sanger Get Funded Today? |
title_full_unstemmed | Would Fred Sanger Get Funded Today? |
title_short | Would Fred Sanger Get Funded Today? |
title_sort | would fred sanger get funded today? |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063904/ https://www.ncbi.nlm.nih.gov/pubmed/24939989 http://dx.doi.org/10.1534/genetics.114.165134 |
work_keys_str_mv | AT fieldsstanley wouldfredsangergetfundedtoday |